Filing Details
- Accession Number:
- 0001127602-13-025744
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-21 16:51:55
- Reporting Period:
- 2013-08-19
- Filing Date:
- 2013-08-21
- Accepted Time:
- 2013-08-21 16:51:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1355818 | L Judy Brown | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-08-19 | 4,973 | $118.74 | 22,406 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-19 | 2,169 | $118.74 | 20,237 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2013-08-20 | 2,600 | $118.52 | 17,637 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-08-20 | 204 | $119.24 | 17,433 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2013-08-19 | 4,973 | $0.00 | 4,973 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-08-19 | 2013-08-19 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on December 7, 2012. This 10b5-1 sales plan will expire on the close of business December 31, 2013.
- The price in column 4 is a weighted average. The prices actually received ranged from $118.14 to $119.05. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $119.20 to $119.40. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Vesting of Restricted Stock Units granted on August 19, 2010.
Billionaire Hedge Funds
